ADC

Highlights from landmark June studies in thoracic oncology.

The most practice-changing, promising, and watchlist data.

Highlights from landmark May studies in thoracic oncology.

Highlights from landmark December studies in thoracic oncology.

Highlights from landmark November studies in thoracic oncology.

Highlights from landmark October studies in thoracic oncology.

The most practice-changing, promising, and watchlist data — distilled into 3 bullets each.

ESMO 2025 brings a strong thoracic-oncology program, spanning peri-operative immunotherapy, next-generation ADCs, and long-term targeted-therapy follow-up. Below are ten key abstracts to keep on your radar.

Ten lung cancer studies to have on your radar across ADCs, peri-op immunotherapy, EGFR with brain mets, and KRAS G12C combos — plus three embargoed heavy-hitters to unveil during plenaries.